Literature DB >> 19415453

Measuring hypomania in the postpartum: a comparison of the Highs Scale and the Altman Mania Rating Scale.

S Smith1, J Heron, S Haque, P Clarke, F Oyebode, I Jones.   

Abstract

We examine the prevalence of hypomania on day 3 postpartum using two self-report mania scales: The Highs Scale and Altman Mania Rating Scale (AMRS). 279 women were recruited from postnatal wards and completed the questionnaires on day 3 postpartum. The scales show good correlation, however, 11% of women meet the suggested threshold for caseness on the Highs Scale and 44% on the AMRS. Hypomanic symptoms are commonly experienced in the early postpartum. Although there is some evidence that the Highs Scale might be conservative, the AMRS likely overestimates hypomania in the postpartum. The definition of what constitutes 'a case' of postnatal hypomania requires further validation against clinical interview and ability to predict variables of clinical importance. Mania scales developed in bipolar disorder populations must be specifically validated for postpartum use.

Entities:  

Mesh:

Year:  2009        PMID: 19415453     DOI: 10.1007/s00737-009-0076-3

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  3 in total

1.  Mania and depression in the perinatal period among women with a history of major depressive disorders.

Authors:  Angela J Inglis; Catriona L Hippman; Prescilla B Carrion; William G Honer; Jehannine C Austin
Journal:  Arch Womens Ment Health       Date:  2014-01-09       Impact factor: 3.633

Review 2.  A closer look at the nosological status of the highs (hypomanic symptoms) in the postpartum period.

Authors:  Verinder Sharma; Priyanka Singh; Christine Baczynski; Mustaq Khan
Journal:  Arch Womens Ment Health       Date:  2020-02-07       Impact factor: 3.633

3.  Validation and Factor Analysis of the Japanese Version of the Highs Scale in Perinatal Women.

Authors:  Aya Yamauchi; Takashi Okada; Masahiko Ando; Mako Morikawa; Yukako Nakamura; Chika Kubota; Masako Ohara; Satomi Murase; Setsuko Goto; Atsuko Kanai; Norio Ozaki
Journal:  Front Psychiatry       Date:  2018-06-28       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.